Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical Trial for Prostate Cancer
This study has been completed.
Study NCT00076531   Information provided by Oakwood Laboratories, LLC
First Received: January 26, 2004   Last Updated: January 24, 2008   History of Changes

January 26, 2004
January 24, 2008
December 2003
November 2004   (final data collection date for primary outcome measure)
 
 
Complete list of historical versions of study NCT00076531 on ClinicalTrials.gov Archive Site
 
 
 
Clinical Trial for Prostate Cancer
 

Phase III trial using an injectable for treatment of prostate cancer.

 
Phase III
Interventional
Treatment, Open Label, Safety/Efficacy Study
Prostate Cancer
Drug: Leuprolide Acetate for Injectable Suspension 22.5 mg
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
 
November 2004   (final data collection date for primary outcome measure)
 
Male
40 Years and older
No
Contact information is only displayed when the study is recruiting subjects
 
 
NCT00076531
 
OL-007
Oakwood Laboratories, LLC
 
Study Chair: James A. Page, M.D. Oakwood Laboratories, LLC
Oakwood Laboratories, LLC
January 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP